median, 7.3 months; 95% CI, 5.9 to 8.8; p=0.26), although the difference did not reach statistical significance.
← all excerpts
Efficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha-Mutated Gastrointestinal Stromal Tumors.
1
—
—